Merrimack Pharmaceuticals, Inc. MACK saw a big move last session, as the company's shares fell more than 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for MACK, as the stock is now down 13.6% since May 29, 2014.
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MACK currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include Actelion Ltd. (ALIOF), ANI Pharmaceuticals, Inc. ANIP and Gilead Sciences Inc. GILD. All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
The company has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
MACK currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the health care sector include Actelion Ltd. (ALIOF), ANI Pharmaceuticals, Inc. ANIP and Gilead Sciences Inc. GILD. All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MERRIMACK PHAR MACK: Free Stock Analysis Report
ACTELION LTD (ALIOF): Get Free Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
GILEAD SCIENCES GILD: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: MoversTrading Ideas
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in